Sign in
4

Changes in Ownership

Chemomab Therapeutics Ltd. Filed Acc 0001178913-23-002227

Options or other derivatives

  • Chief Financial Officer acquired 167,860 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fatal Sigal · Chief Financial Officer

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-06-14 Grant or award : show line 1 in the form Option to Purchase American Depositary Shares +102,860 167,860 D
2022-11-08 Grant or award : show line 2 in the form Option to Purchase American Depositary Shares +29,400 65,000 D
2021-11-11 Grant or award : show line 3 in the form Option to Purchase American Depositary Shares +35,600 35,600 D
Loading xslF345X04/ownership.xml…